ARTICLE | Clinical News
Loratadine/montelukast regulatory update
June 30, 2008 7:00 AM UTC
Schering-Plough and Merck withdrew an NDA for a fixed-dose combination tablet of loratadine and montelukast to treat allergic rhinitis. In April, the companies received a not approvable letter from FD...